Last updated: February 2, 2022
Sponsor: Misook L. Chung
Overall Status: Completed
Phase
N/A
Condition
Heart Failure
Congestive Heart Failure
Chest Pain
Treatment
N/AClinical Study ID
NCT03560206
46045
R01NR012967
Ages 21-90 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Eligible patients will:
- have diagnosis of chronic HF with either preserved or reduced ejection fraction
- have a dedicated primary family caregiver
- be able to speak and write English Eligible caregivers will:
- be a primary caregiver identified by the patient
- the spouse, committed partner, or family member living with the HF patient
- be able to speak and understand English
- have no obvious major clinical cognitive impairment that would impair ability to giveinformed consent
- have no major co-morbidities (i.e. HF, cancer, renal/liver failure, or uncontrolleddiabetes as determined by self-report).
Exclusion
Exclusion Criteria: Patients will be excluded if they have:
- major clinical cognitive impairment (i.e., dementia, Alzheimer disease, and severestroke)
- a co-existing terminal illness (e.g., cancer)
- a referral for heart transplantation
- a dietary prescription that prevents following a 2-3 gram sodium diet (e.g., cliniciandoes not support use of a SRD).
- no dedicated caregivers
Study Design
Total Participants: 316
Study Start date:
March 01, 2015
Estimated Completion Date:
July 31, 2020
Study Description
Connect with a study center
University of Kentucky HealthCare
Lexington, Kentucky 40536
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.